Fresh analysis reveals that patients who come off popular GLP-1 drugs like semaglutide or tirzepatide can put back on shed pounds at a significantly accelerated pace than those who halt conventional diet and exercise programs.
Research printed in a prominent medical journal demonstrates that while overweight individuals often shed a large proportion of their total mass while using the jabs, the mass returns at an average rate of nearly a kilo each month once they quit.
"Users buying such medications need to be cognizant of the potential of fast weight regain when the medication concludes," cautioned lead investigator Dr. Susan Jebb.
That rate of regain implies a reversion to original mass in about a year and a half.
Analyzing Treatments
The study, which reviewed 37 of trials involving over 9,000 of participants, contrasted the results of the injectable medications with other pills.
The team point out that individuals who shed pounds through dieting usually see a slower creep back—around 0.1 kg a month—post-intervention.
Understanding the Fast Rebound
Nutrition scientists suggest the way of the jabs accounts for the heightened regain.
These medications copy a natural hormone called glucagon-like peptide-1, which controls appetite.
"Long-term administration of the hormone levels several times higher than the body's typical production may cause the system to produce less of its own natural hormone, and could lessen sensitivity to its actions," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this GLP-1 'fix' means appetite is unsuppressed, making excessive eating far more likely."
A Lifelong Disease?
The NHS advise the injections for individuals with obesity-related medical conditions, accompanied by prescribed lifestyle changes.
Professionals argue that, given the likelihood of relapse, the therapy should be considered ongoing.
This opinion is supported by drug manufacturers, who note that the results "emphasize the chronic character of excess weight," akin to managing conditions like hypertension.
User Testimonies
People who have discontinued the jabs report a powerful resurgence of appetite.
"It felt as if something activating and you're instantly ravenous," said one woman.
This difficulty is compounded if users have not established lasting lifestyle or habit modifications during therapy.
Widespread Use
Figures indicate that millions of adults in the UK have tried these injections in the last 12 months, with demand being substantial.
- Adoption is greater among women compared to men.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion obtain the medications through private healthcare rather than the NHS.
In conclusion, experts stress that while these medications are effective tools for shedding pounds, they are not a magic solution and lasting health benefits likely depends on integrated lifestyle changes.
